These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21040776)

  • 1. Cynomolgus macaque model for pneumonic plague.
    Warren R; Lockman H; Barnewall R; Krile R; Blanco OB; Vasconcelos D; Price J; House RV; Bolanowksi MA; Fellows P
    Microb Pathog; 2011 Jan; 50(1):12-22. PubMed ID: 21040776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92.
    Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Baze WB; Suarez G; Peterson JW; Chopra AK
    Microbes Infect; 2009 Feb; 11(2):205-14. PubMed ID: 19073275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).
    Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK
    Vaccine; 2010 Nov; 28(49):7748-56. PubMed ID: 20920572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.
    Van Andel R; Sherwood R; Gennings C; Lyons CR; Hutt J; Gigliotti A; Barr E
    Comp Med; 2008 Feb; 58(1):68-75. PubMed ID: 19793459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule.
    Fellows P; Lin W; Detrisac C; Hu SC; Rajendran N; Gingras B; Holland L; Price J; Bolanowski M; House RV
    Clin Vaccine Immunol; 2012 Apr; 19(4):468-76. PubMed ID: 22336286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague.
    Anderson PE; Olson RM; Willix JL; Anderson DM
    Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milestones in progression of primary pneumonic plague in cynomolgus macaques.
    Koster F; Perlin DS; Park S; Brasel T; Gigliotti A; Barr E; Myers L; Layton RC; Sherwood R; Lyons CR
    Infect Immun; 2010 Jul; 78(7):2946-55. PubMed ID: 20385751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septic shock and nonpulmonary organ dysfunction in pneumonic plague: the role of Yersinia pestis pCD1- vs. pgm- virulence factors.
    Doyle TM; Matuschak GM; Lechner AJ
    Crit Care Med; 2010 Jul; 38(7):1574-83. PubMed ID: 20400901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92.
    Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Parham TE; Baze WB; Suarez G; Peterson JW; Chopra AK
    Microbiology (Reading); 2008 Jul; 154(Pt 7):1939-1948. PubMed ID: 18599822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant-produced plague vaccine candidate confers protection to monkeys.
    Mett V; Lyons J; Musiychuk K; Chichester JA; Brasil T; Couch R; Sherwood R; Palmer GA; Streatfield SJ; Yusibov V
    Vaccine; 2007 Apr; 25(16):3014-7. PubMed ID: 17287055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
    Reed DS; Martinez MJ
    Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental model to evaluate the human body louse as a vector of plague.
    Houhamdi L; Lepidi H; Drancourt M; Raoult D
    J Infect Dis; 2006 Dec; 194(11):1589-96. PubMed ID: 17083045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.
    Chichester JA; Musiychuk K; Farrance CE; Mett V; Lyons J; Mett V; Yusibov V
    Vaccine; 2009 May; 27(25-26):3471-4. PubMed ID: 19200825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.
    Layton RC; Brasel T; Gigliotti A; Barr E; Storch S; Myers L; Hobbs C; Koster F
    J Med Primatol; 2011 Feb; 40(1):6-17. PubMed ID: 20722770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).
    Davis KJ; Fritz DL; Pitt ML; Welkos SL; Worsham PL; Friedlander AM
    Arch Pathol Lab Med; 1996 Feb; 120(2):156-63. PubMed ID: 8712895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.